Indication
Trulicity is indicated for the treatment of patients 10 years and above with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as monotherapy when metformin is considered inappropriate due to intolerance or contraindications in addition to other medicinal products for the treatment of diabetes. For study results with respect to combinations, effects on glycaemic control and cardiovascular events, and the populations studied, see sections 4.4, 4.5 and 5.1.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- TRULICITY 3 mg SOLUCION INYECTABLE EN PLUMA PRECARGADASpain · 3 mgAuthorised
- TRULICITY 4,5 mg SOLUCION INYECTABLE EN PLUMA PRECARGADASpain · 4,5 mgAuthorised
- Trulicity 0,75 mg oplossing voor injectie in voorgevulde injectiespuitNetherlandsAuthorised
- Trulicity 0,75 mg oplossing voor injectie in voorgevulde pen